Fleur Chandler

Background

About Fleur Chandler

Head of Market Access UK and Ireland at Sanofi. Privileged to take on leadership of one of the best teams in the industry, spanning HEOR, value & access, pricing and field market access, engaging with the NHS, across the Sanofi portfolio, covering specialty care, vaccines and general medicines. In the charity sector with Duchenne UK, I conceptualised and now lead Project HERCULES, an innovative global collaboration across nine industry partners, academia, patient organisations and global HTA bodies, generating a gold standard disease level evidence base for Duchenne Muscular Dystrophy. I was privileged to speak at the opening plenary of US ISPOR 2019. My previous time was at GSK within the Value Evidence and Outcomes (VEO) organisation : leading on access and reimbursement for the respiratory portfolio accountable for ensuring GSK develops medicines of value to patients, providers and payers. During this time I enjoyed working closely with our medical and commercial franchise colleagues, leading multiple HTAs globally and being part of the landmark SUMMIT trial and the Salford Lung Study. I am passionate about ensuring delivering the right evidence to enable the right patients to access appropriate medicines. Specialities: Health Economics, market access, health technology assessment, rare disease, patient advocacy and engagement